Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting KRAS in Pancreatic Ductal Adenocarcinoma: The Long Road to Cure
Victor Hugo Fonseca de Jesus, Maria Cecília Mathias-Machado, João Paulo Fogacci de Farias, et al.
Cancers (2023) Vol. 15, Iss. 20, pp. 5015-5015
Open Access | Times Cited: 17

Showing 17 citing articles:

Targeting KRAS in pancreatic cancer
Sandra Stickler, Barbara H. Rath, Gerhard Hamilton
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics (2024) Vol. 32, Iss. 5, pp. 799-805
Open Access | Times Cited: 18
Consensus, debate, and prospective on pancreatic cancer treatments
Junke Wang, Jie Yang, Amol Narang, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 11
Inhibition of the RAF/MEK/ERK Signaling Cascade in Pancreatic Cancer: Recent Advances and Future Perspectives
Christos Adamopoulos, Donatella Delle Cave, Athanasios G. Papavassiliou
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 3, pp. 1631-1631
Open Access | Times Cited: 9
MYC and KRAS cooperation: from historical challenges to therapeutic opportunities in cancer
Sílvia Casacuberta‐Serra, Íñigo González-Larreategui, Daniel Capitán-Leo, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 8
Evaluation of KRAS inhibitor-directed therapies for pancreatic cancer treatment
Szu-Aun Long, Amber M. Amparo, Grace Goodhart, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 5
Pancreatic Ductal Adenocarcinoma with Medullary Features and a Complete Pathological Response After Neoadjuvant FOLFIRINOX: A Case Report and Literature Review
Rodrigo G. Taboada, Maria Fernanda Arruda Almeida, Karina Miranda Santiago, et al.
Journal of Gastrointestinal Cancer (2025) Vol. 56, Iss. 1
Closed Access
Fast-Relaxing Hydrogels Promote Pancreatic Adenocarcinoma Cell Aggressiveness through Integrin β1 Signaling
Han Nguyen, Ngoc Ha Luong, Jacqueline Peil, et al.
Biomacromolecules (2025)
Closed Access
Comprehensive Genomic Studies on the Cell Blocks of Pancreatic Cancer
Ricella Souza da Silva, Maria João Pina, Luı́s Cirnes, et al.
Diagnostics (2024) Vol. 14, Iss. 9, pp. 906-906
Open Access | Times Cited: 3
The Target Therapy Hyperbole: “KRAS (p.G12C)”—The Simplification of a Complex Biological Problem
Massimiliano Chetta, Anna Basile, Marina Tarsitano, et al.
Cancers (2024) Vol. 16, Iss. 13, pp. 2389-2389
Open Access | Times Cited: 1
The Evolving Role of Neoadjuvant Radiation Therapy in Pancreatic Adenocarcinoma
J.M. Bryant, Justyn Nakashima, V. Khatri, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 22, pp. 6800-6800
Open Access | Times Cited: 1
Genomic determinants of biological aggressiveness and poor prognosis of pancreatic cancers: KRAS and beyond
Calogero Ciulla, Claudio Luchini
Expert Review of Molecular Diagnostics (2024) Vol. 24, Iss. 5, pp. 355-362
Closed Access
Cytologic testing for mismatch repair deficiency/microsatellite instability and NTRK gene fusion is not routinely indicated in primary pancreaticobiliary carcinoma cell block material
Courtney Connelly, William S. Towne, Niyati Desai, et al.
Journal of the American Society of Cytopathology (2024) Vol. 13, Iss. 6, pp. 413-419
Open Access
Exploring the Role of CBX3 as a Potential Therapeutic Target in Lung Cancer
Muhammad Aamir Wahab, Nunzio Del Gaudio, Biagio Gargiulo, et al.
Cancers (2024) Vol. 16, Iss. 17, pp. 3026-3026
Open Access
The role of autophagy in pancreatic diseases
Wengang Zhang, Qing-Zhen Wu, Bo‐Zong Shao
Frontiers in Pharmacology (2024) Vol. 15
Open Access
KRAS inhibitors in drug resistance and potential for combination therapy
Lala S. Rathod, Nikhil S. Sakle, Santosh N. Mokale
Tumori Journal (2024)
Closed Access
Personalized nutrition after discharge for pancreatic surgery: A study protocol
Erica Pizzocaro, Roberta Vella, Isabella Frigerio, et al.
Nutrition and Health (2024)
Closed Access
Machine learning predicts metastatic progression using novel differentially expressed lncRNAs as potential markers in pancreatic cancer
Hasan Alsharoh
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Page 1

Scroll to top